Manufacturers Life Insurance Company, The Revance Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 39,386 shares of RVNC stock, worth $101,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,386
Previous 40,685 3.19%
Holding current value
$101,222
Previous $104,000 2.88%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-1,299 Reduced 3.19%
39,386 $101,000
Q3 2024

Nov 13, 2024
SELL
$2.57 - $2.57 $4,140 - $4,140
-1,611 Reduced 3.81%
40,685 $104,000
Q2 2024

Aug 14, 2024
BUY
$2.34 - $4.73 $22,466 - $45,412
9,601 Added 29.37%
42,296 $108,000
Q1 2024

May 14, 2024
SELL
$4.65 - $9.31 $34,991 - $70,057
-7,525 Reduced 18.71%
32,695 $160,000
Q4 2023

Feb 13, 2024
SELL
$5.81 - $11.2 $7,855 - $15,142
-1,352 Reduced 3.25%
40,220 $353,000
Q3 2023

Nov 15, 2023
BUY
$11.47 - $25.07 $94,742 - $207,078
8,260 Added 24.8%
41,572 $476,000
Q2 2023

Aug 11, 2023
BUY
$24.7 - $37.61 $67,035 - $102,073
2,714 Added 8.87%
33,312 $843,000
Q1 2023

May 15, 2023
BUY
$18.36 - $35.27 $19,810 - $38,056
1,079 Added 3.53%
31,677 $1.02 Million
Q4 2022

Aug 11, 2023
BUY
$18.32 - $30.66 $57,909 - $96,916
3,161 Added 11.52%
30,598 $564,000
Q4 2022

Feb 13, 2023
BUY
$18.32 - $30.66 $57,909 - $96,916
3,161 Added 11.52%
30,598 $564,000
Q3 2022

Aug 11, 2023
SELL
$14.33 - $28.47 $7,064 - $14,035
-493 Reduced 1.77%
27,437 $740,000
Q3 2022

Nov 03, 2022
SELL
$14.33 - $28.47 $7,064 - $14,035
-493 Reduced 1.77%
27,437 $741,000
Q2 2022

Aug 11, 2023
SELL
$11.52 - $20.4 $13,052 - $23,113
-1,133 Reduced 3.9%
27,930 $385,000
Q2 2022

Aug 15, 2022
SELL
$11.52 - $20.4 $13,052 - $23,113
-1,133 Reduced 3.9%
27,930 $386,000
Q1 2022

Aug 11, 2023
SELL
$12.36 - $20.31 $32,309 - $53,090
-2,614 Reduced 8.25%
29,063 $566,000
Q1 2022

May 20, 2022
SELL
$12.36 - $20.31 $97,841 - $160,773
-7,916 Reduced 21.41%
29,063 $567,000
Q4 2021

Feb 16, 2022
BUY
$12.46 - $27.87 $6,367 - $14,241
511 Added 1.4%
36,979 $603,000
Q3 2021

Nov 12, 2021
SELL
$25.78 - $33.21 $77,520 - $99,862
-3,007 Reduced 7.62%
36,468 $1.02 Million
Q2 2021

Aug 12, 2021
BUY
$26.8 - $31.84 $98,382 - $116,884
3,671 Added 10.25%
39,475 $1.17 Million
Q1 2021

May 03, 2021
SELL
$24.03 - $29.97 $48,756 - $60,809
-2,029 Reduced 5.36%
35,804 $1 Million
Q4 2020

Feb 12, 2021
BUY
$23.41 - $28.34 $53,257 - $64,473
2,275 Added 6.4%
37,833 $1.07 Million
Q3 2020

Nov 09, 2020
BUY
$23.23 - $34.3 $43,021 - $63,523
1,852 Added 5.49%
35,558 $894,000
Q2 2020

Aug 10, 2020
BUY
$12.6 - $26.55 $32,545 - $68,578
2,583 Added 8.3%
33,706 $862,000
Q1 2020

May 15, 2020
BUY
$12.46 - $27.81 $55,608 - $124,116
4,463 Added 16.74%
31,123 $461,000
Q4 2019

Feb 14, 2020
SELL
$11.66 - $20.15 $18,481 - $31,937
-1,585 Reduced 5.61%
26,660 $433,000
Q3 2019

Nov 12, 2019
SELL
$10.22 - $14.5 $235 - $333
-23 Reduced 0.08%
28,245 $389,000
Q2 2019

Aug 14, 2019
BUY
$10.67 - $15.49 $28,712 - $41,683
2,691 Added 10.52%
28,268 $367,000
Q1 2019

May 13, 2019
BUY
$15.4 - $20.39 $75,136 - $99,482
4,879 Added 23.57%
25,577 $403,000
Q4 2018

Feb 14, 2019
SELL
$18.06 - $24.96 $26,963 - $37,265
-1,493 Reduced 6.73%
20,698 $417,000
Q3 2018

Nov 14, 2018
SELL
$23.55 - $30.1 $60,711 - $77,597
-2,578 Reduced 10.41%
22,191 $552,000
Q2 2018

Aug 14, 2018
BUY
$27.45 - $33.35 $118,666 - $144,172
4,323 Added 21.14%
24,769 $680,000
Q1 2018

May 15, 2018
BUY
$29.15 - $37.4 $66,287 - $85,047
2,274 Added 12.51%
20,446 $630,000
Q4 2017

Feb 08, 2018
BUY
$24.55 - $36.3 $5,744 - $8,494
234 Added 1.3%
18,172 $650,000
Q3 2017

Nov 14, 2017
BUY
$22.55 - $28.1 $404,501 - $504,057
17,938
17,938 $495,000

Others Institutions Holding RVNC

# of Institutions
208
Shares Held
80.9M
Call Options Held
2.26M
Put Options Held
5.48M
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email